期刊文献+

《2009年NCCN肿瘤学临床实践指南》关于胃肠间质瘤内容解读 被引量:2

《2009年NCCN肿瘤学临床实践指南》关于胃肠间质瘤内容解读
原文传递
导出
摘要 胃肠间质瘤(gastrointestinal stromal tumors,GIST)是消化道最常见的间叶组织来源的肿瘤。目前认为,从分子生物学和临床两个方面来说,GIST都是一种特殊类型。许多临床医师对GIST并不熟悉,认识尚停留在“胃肠道平滑肌瘤,肉瘤”水平上,以致临床诊断、治疗方案相当混乱而且无序,循证医学的内容更少。如何逐步实现规范化、标准化,做到诊疗有章可循是临床上应重视的问题。
作者 梁小波
机构地区 山西省肿瘤医院
出处 《中国实用外科杂志》 CSCD 北大核心 2010年第4期288-290,共3页 Chinese Journal of Practical Surgery
  • 相关文献

参考文献13

  • 1de Matteo R, Lewis J J, Leung D, el al.Two hundred gastrointestinal stromal tumors: recurrence patterns and pognostion factors for survival [ J ] .Ann Surg,2000,231 (1):51-58.
  • 2Mudan SS, Conlon KC, Woodruff JM, et a l. Salvge surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection[J].Cancer,2000,88(1):66-74.
  • 3Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy [ J ].Ann Surg Oncol,2004,11 (5):465-475.
  • 4Dematteo RP, Ballman KV, Antonescu CR, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial [ J ]. Lancet, 2009, 373 (9669): 1097-1104.
  • 5Avritscher R, Gupta S.Gastrointestinal stromal tumor: role of interventional radiology in diagnosis and treatment [J]. Hematol Oncol Clin North Am, 2009, 23(1):129-137.
  • 6Hasegawa J, Kanda T, Hirota S, et al. Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy [J]. Int J Clin Oncol, 2007,12 (3): 212-217.
  • 7Dileo P, Randhawa R, Vansonnenberg E, et al. Safety and efficacy of percutaneous radio-frequency (RFA) in patients with metastatic gastrointestinal stromal tumor (GIST) with clonal evolution of lesions refractory to imatinib mesylate [J ]. J Clin Oncol, 2004, 22(24):9024.
  • 8杜春燕,师英强.胃肠道间质瘤的辅助治疗[J].中国实用外科杂志,2006,26(8):625-628. 被引量:13
  • 9周雷,王正康,杜家文,宋新,王岩,黄林平,王文跃,潘瑞芹.胃肠道间质瘤的免疫组化分析及临床诊治[J].中国实用外科杂志,2005,25(9):548-550. 被引量:4
  • 10Debiec-Rychter M, Sciot R, Le cesne A, et al. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumors,EORTC soft Tissue and bone Sarcoma Group.The Italian Sarcoma Group.Australasian Gastroiznlestinal Trails Group [J]. Eur J Cancer,2006,42(8): 1093-1103.

二级参考文献41

  • 1席吕刚,蔡端.胃肠道间质瘤35例诊治分析[J].中国实用外科杂志,2005,25(3):151-153. 被引量:27
  • 2Fletcher CD,Bermen JJ,Corless C,et al.Diagnosis of gastrointestinal stromal tumors.Hum Pathol,2002,33(5):459-465.
  • 3Mazur MT,Clark HB.Gastric stromal tumors:Reappraisal of histogenesis.Am J Surg Pathol,1983,7(6):507-519.
  • 4Kindblom LG,Remotti HE,Aldenborg F.Gastrointestinal pacemaker cell tumor(GIPACT):Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.Am J Pathol,1998,152(5):1259-1269.
  • 5Miettinen M,Lasota J.Gastrointestinal stromal tumors-definition,clinical,histological,immunohistochemical, and molecular genetic features and differential diagnosis.Virchows Arch,2001,438(1):1-12.
  • 6Kim TW,Lee H,Kang YK,et al.Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors.Clin Cancer Res,2004,10(9):3076-3081.
  • 7Emory TS,Sobin LH,Lukers L,et al.Prognosis of gastrointestinal smooth-muscle(stromal) tumors.Am J Surg Pathol,1999,23(1):82-87.
  • 8Hirota S,Isozaki K,Moriyama Y,et al.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.Science,1998,279(5350):577-580.
  • 9DeMatteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors.Ann Surg,2000,231(1):51-58.
  • 10Verweij J,Casali PG,Zalcberg J,et al.Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib:randomised trial.Lancet,2004,364(9440):1127-1134.

共引文献15

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部